XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1
REVENUE (Tables)
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Total Revenue by Type and by U.S versus Rest of World
The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):
Three months ended June 30,
20242023
(in millions)U.S.RoWTotalU.S.RoWTotal
Testing revenues:
Hereditary Cancer$80.9 $10.6 $91.5 $64.5 $12.2 $76.7 
Tumor Profiling26.7 5.9 32.6 27.3 8.7 36.0 
Prenatal44.2 0.2 44.4 35.4 0.2 35.6 
Pharmacogenomics43.0 — 43.0 35.2 — 35.2 
Total revenue$194.8 $16.7 $211.5 $162.4 $21.1 $183.5 
Six months ended June 30,
20242023
(in millions)U.S.RoWTotalU.S.RoWTotal
Testing revenues:
Hereditary Cancer$157.2 $22.4 $179.6 $128.5 $23.9 $152.4 
Tumor Profiling50.6 12.9 63.5 56.1 17.2 73.3 
Prenatal88.3 0.4 88.7 71.4 0.4 71.8 
Pharmacogenomics81.9 — 81.9 67.2 — 67.2 
Total revenue$378.0 $35.7 $413.7 $323.2 $41.5 $364.7